Sanara MedTech Inc.
SMTIUS売上高
$103M
百万USD
営業利益
$7M
百万USD
純利益
$-38M
百万USD
ROE
-632.5%
最新FY
EPS
$-4.36
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-1M | - |
| FY2021 | Q2 | - | $-1M | - |
| FY2021 | Q3 | - | $-2M | - |
| FY2021 | FY | $24M | $-8M | - |
| FY2022 | Q1 | $8M | $-3M | - |
| FY2022 | Q2 | $10M | $-3M | - |
| FY2022 | Q3 | $13M | $-2M | $0.09 |
| FY2022 | FY | $46M | $-8M | - |
| FY2023 | Q1 | $16M | $-1M | - |
| FY2023 | Q2 | $16M | $-2M | $-0.22 |
| FY2023 | Q3 | $16M | $-1M | $-0.13 |
| FY2023 | FY | $65M | $-4M | $-0.52 |
| FY2024 | Q1 | $19M | $-2M | $-0.21 |
| FY2024 | Q2 | $20M | $-4M | $-0.41 |
| FY2024 | Q3 | $22M | $-3M | $-0.34 |
| FY2024 | FY | $87M | $-10M | $-1.14 |
| FY2025 | Q1 | $23M | $-4M | $-0.41 |
| FY2025 | Q2 | $26M | $-2M | $-0.23 |
| FY2025 | Q3 | $26M | $-30M | $-3.40 |
| FY2025 | FY | $103M | $-38M | $-4.36 |
| FY2026 | Q1 | $28M | $0M | $0.05 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | $24M | $46M | $65M | $87M | $103M |
| 営業利益 | $-0M | $0M | $-1M | - | $-5M | $-7M | $-12M | $-4M | $-7M | $7M |
| 純利益 | $-0M | $0M | $-1M | - | $-4M | $-8M | $-8M | $-4M | $-10M | $-38M |
| 総資産 | $2M | $2M | $3M | $11M | $10M | $36M | $61M | $74M | $88M | $73M |
| 純資産 | - | - | - | $6M | $6M | $30M | $42M | $45M | $39M | $6M |
| 自己資本 | $-0M | $0M | $1M | $7M | $6M | $31M | $42M | $45M | $39M | $6M |
| 営業CF | $0M | $-0M | $0M | - | $-4M | $-5M | $-6M | $-3M | $-0M | $7M |
| EPS | - | $0.00 | $0.00 | - | $-0.76 | - | - | $-0.52 | $-1.14 | $-4.36 |
| BPS | $-0.00 | $0.00 | $0.00 | $1.10 | $0.81 | $3.92 | $4.99 | $5.20 | $4.43 | $0.65 |
| ROE | 98.3% | 323.1% | -54.0% | - | -70.8% | -26.1% | -19.0% | -9.6% | -24.5% | -632.5% |